Diane Hollenbaugh

8.6k total citations · 3 hit papers
75 papers, 7.0k citations indexed

About

Diane Hollenbaugh is a scholar working on Immunology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Diane Hollenbaugh has authored 75 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 34 papers in Molecular Biology and 17 papers in Immunology and Allergy. Recurrent topics in Diane Hollenbaugh's work include T-cell and B-cell Immunology (23 papers), Immune Cell Function and Interaction (19 papers) and Cell Adhesion Molecules Research (17 papers). Diane Hollenbaugh is often cited by papers focused on T-cell and B-cell Immunology (23 papers), Immune Cell Function and Interaction (19 papers) and Cell Adhesion Molecules Research (17 papers). Diane Hollenbaugh collaborates with scholars based in United States, Germany and Sweden. Diane Hollenbaugh's co-authors include Alejandro Aruffo, Christian P. Larsen, Thomas C. Pearson, Diane Z. Alexander, Hans D. Ochs, Shannon C. Ritchie, Eric T. Elwood, Peter S. Linsley, Rose Hendrix and Ivan Stamenkovic and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Diane Hollenbaugh

74 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

1996 1.2k citations Christian P. Larsen, Eric T. Elwood et al. profile →
The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome

1993 663 citations Alejandro Aruffo, Diane Hollenbaugh et al. profile →
Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular Proteome

2008 615 citations Kevin Hestir, Elizabeth Bosch et al. profile →

Peers

Countries citing papers authored by Diane Hollenbaugh

Since Specialization

Citations

This map shows the geographic impact of Diane Hollenbaugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Hollenbaugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Hollenbaugh more than expected).

Fields of papers citing papers by Diane Hollenbaugh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane Hollenbaugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Hollenbaugh. The network helps show where Diane Hollenbaugh may publish in the future.

Co-authorship network of co-authors of Diane Hollenbaugh

This figure shows the co-authorship network connecting the top 25 collaborators of Diane Hollenbaugh. A scholar is included among the top collaborators of Diane Hollenbaugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane Hollenbaugh. Diane Hollenbaugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity 2020 ·Molecular Cancer Therapeutics ·(unknown), (unknown), Archana Thakur, Melvin Fox, (unknown), Enrico L. DiGiammarino, Li Zhou, Mien Sho, Belinda Cairns, (unknown), (unknown), Josue Samayoa, C.M. Forsyth, David B. Powers, Debra T. Chao, Diane Hollenbaugh, Hamsell M. Alvarez, Yoshiko Akamatsu	30
2	A Bispecific Molecule Targeting CD40 and Tumor Antigen Mesothelin Enhances Tumor-Specific Immunity 2019 ·Cancer Immunology Research ·Shiming Ye, (unknown), Nicole A. Belmar, (unknown), (unknown), Mien Sho, Yoshiko Akamatsu, Han Kim, (unknown), (unknown), Marc Lake, Danying Song, John E. Harlan, (unknown), (unknown), Alan F. Wahl, Patricia Culp, Diane Hollenbaugh, Debra T. Chao	40
3	LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates 2018 ·Cancer Research ·James W. Purcell, (unknown), Jonathan A. Hickson, Melvin Fox, Mien Sho, Lisa Durkin, Tamar Uziel, Rick Powers, Kelly Foster, Thomas McGonigal, (unknown), Josue Samayoa, Dong Zhang, Joann P. Palma, (unknown), Diane Hollenbaugh, Kurt Gish, Susan E. Morgan-Lappe, Eric D. Hsi, Debra T. Chao	136
4	FP-1039 (FGFR1:Fc), a soluble FGFR1 receptor antagonist, inhibits tumor growth and angiogenesis 2007 ·Molecular Cancer Therapeutics ·Hongbing Zhang, (unknown), Kevin P. Baker, Ali Sadra, Elizabeth Bosch, (unknown), Stephen K. Doberstein, (unknown), Kevin Hestir, Diane Hollenbaugh, (unknown), Minmin Qin, Lewis T. Williams	11
5	Novel inhibitors of IMPDH 2003 ·Bioorganic & Medicinal Chemistry Letters ·Scott H. Watterson, (unknown), T. G. Murali Dhar, Zhongqi Shen, William J. Pitts, Junqing Guo, Henry H. Gu, Derek Norris, John S. Chorba, Ping Chen, Daniel L. Cheney, Mark R. Witmer, Catherine Fleener, Katherine A. Rouleau, Robert M. Townsend, Diane Hollenbaugh, Edwin J. Iwanowicz	23
6	Identification of novel and potent isoquinoline aminooxazole-Based IMPDH inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Ping Chen, Derek Norris, (unknown), T. G. Murali Dhar, William J. Pitts, Scott H. Watterson, Daniel L. Cheney, Donna A. Bassolino, Catherine Fleener, Katherine A. Rouleau, Diane Hollenbaugh, (unknown), Joel C. Barrish, Edwin J. Iwanowicz	21
7	3-Cyanoindole-based inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure–Activity relationships 2003 ·Bioorganic & Medicinal Chemistry Letters ·T. G. Murali Dhar, Zhongqi Shen, Henry H. Gu, Ping Chen, Derek Norris, Scott H. Watterson, Shelley K. Ballentine, Catherine Fleener, Katherine A. Rouleau, Joel C. Barrish, Robert M. Townsend, Diane Hollenbaugh, Edwin J. Iwanowicz	31
8	Anti-CD40 therapy extends renal allograft survival in rhesus macaques1 2002 ·Transplantation ·Thomas C. Pearson, Joel Trambley, (unknown), Daniel C. Anderson, Shannon Cowan, Robert A. Bray, Angello Lin, Diane Hollenbaugh, Alejandro Aruffo, Anthony W. Siadak, Elizabeth Strobert, (unknown), Christian P. Larsen	135
9	The TosMIC approach to 3-(Oxazol-5-yl) indoles: application to the synthesis of indole-based IMPDH inhibitors 2002 ·Bioorganic & Medicinal Chemistry Letters ·T. G. Murali Dhar, Zhongqi Shen, Catherine Fleener, Katherine A. Rouleau, Joel C. Barrish, Diane Hollenbaugh, Edwin J. Iwanowicz	16
10	Therapeutic intervention with inhibitors of co-stimulatory pathways in autoimmune disease 2001 ·Current Opinion in Immunology ·Alejandro Aruffo, Diane Hollenbaugh	29
11	Cutting Edge: CD40 Ligand Is a Limiting Factor in the Humoral Response to T Cell-Dependent Antigens 1999 ·The Journal of Immunology ·(unknown), Diane Hollenbaugh, Christopher B. Wilson	43
12	PROLONGED ACCEPTANCE OF CONCORDANT AND DISCORDANT XENOGRAFTS WITH COMBINED CD40 AND CD28 PATHWAY BLOCKADE1 1998 ·Transplantation ·Eric T. Elwood, Christian P. Larsen, Hong Rae Cho, Matthias Corbascio, Shannon C. Ritchie, Diane Z. Alexander, Carol Tucker‐Burden, Peter S. Linsley, Alejandro Aruffo, Diane Hollenbaugh, Kevin J. Winn, Thomas C. Pearson	102
13	Agonistic activity of a CD40-specific single-chain Fv constructed from the variable regions of mAb G28-5. 1997 ·PubMed ·J A Ledbetter, J A Francisco, Clay B. Siegall, Lisa K. Gilliland, Diane Hollenbaugh, Alejandro Aruffo, Anthony W. Siadak, (unknown), Laura S. Grosmaire, (unknown), T J Brown, (unknown), Robert S. Mittler, Peter A. Kiener, Steven G. Nadler	5
14	Induction of costimulatory molecules B7-1 and B7-2 in murine B cells: The CBAN mouse reveals a role for Bruton's tyrosine kinase in CD40-mediated B7 induction 1996 ·Molecular Immunology ·(unknown), Mark DeBenedette, Diane Hollenbaugh, Tania H. Watts	28
15	Cleavable CD40Ig fusion proteins and the binding to sgp39 1995 ·Journal of Immunological Methods ·Diane Hollenbaugh, (unknown), (unknown), Alejandro Aruffo	20
16	The Human gp39 Promoter 1995 ·Journal of Biological Chemistry ·Lisa Schubert, G. J. King, Randy Q. Cron, David B. Lewis, Alejandro Aruffo, Diane Hollenbaugh	81
17	Effects of Chemical Modification on the Binding Activities of P-Selectin Mutants 1995 ·Biochemistry ·Diane Hollenbaugh, Alejandro Aruffo, Peter D. Senter	11
18	The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIGM1. 1994 ·Journal of Clinical Investigation ·Diane Hollenbaugh, Liangyu Wu, Hans D. Ochs, Shigeaki Nonoyama, Laura S. Grosmaire, J A Ledbetter, Randolph J. Noelle, Helen Hill, Alejandro Aruffo	48
19	B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. 1993 ·The Journal of Experimental Medicine ·Shigeaki Nonoyama, Diane Hollenbaugh, Alejandro Aruffo, J A Ledbetter, HD Ochs	129
20	Interaction of P-selectin (CD62) and its cellular ligand: Analysis of critical residues 1993 ·Biochemistry ·Diane Hollenbaugh, Jürgen Bajorath, Ronald E. Stenkamp, A Aruffo	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact